Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efavirenz vs. Rilpivirine on Endothelial Function in Healthy Volunteers
NCT01585038Phase 4Completed
- Sponsor
- Indiana University
- Start
- Jul 2012
- Primary completion
- May 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of rilpivirine in human immunodeficiency virus infection (HIV), sponsored by Indiana University. Started Jul 2012; status: completed.
02
Drugs
rilpivirine
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT01585038.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01585038.